KENIRAX

KENIRAX is a pharmaceutical cough syrup formulation containing Dextromethorphan Hydrobromide and Chlorpheniramine Maleate. The product is presented as an oral liquid formulation and is included in the Cough Syrup segment of the Suprimeda pharmaceutical portfolio. The documented composition combines a centrally acting cough suppressant with an antihistamine in a single liquid dosage form.

Dextromethorphan Hydrobromide and Chlorpheniramine Maleate are the two active pharmaceutical ingredients specified for KENIRAX. The combination provides a clearly defined formulation for professional pharmaceutical identification, cataloguing and institutional procurement. The product is available as a syrup, offering a liquid dosage form within the respiratory and cough-care product segment.

For hospitals, doctors, healthcare institutions and pharmaceutical procurement teams, KENIRAX Syrup can be identified through its active ingredients, formulation type and standardized packaging. The product is supplied in a 100 ml bottle, providing a defined pack configuration for pharmaceutical product listings and procurement requirements.